Patient P-02065
Synthetic patientMETA-24 · Day 177 · 45–54 · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
6%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S09
- Day 21 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 21.
Primary contributors, last 14 days
- GI instability-16
- Inflammatory activity-16
- Nutritional resilience+11
- Toxicity-3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable38 min
worsening · -5.8 vs previous 14 d
Sleep duration
Wearable6.7 h
stable · +0.0 vs previous 14 d
Energy level
Daily log6.8/10
stable · +0.1 vs previous 14 d
Steps
Wearable4,907
worsening · -618 vs previous 14 d
GI burden
Companion5/100
improving · -1.6 vs previous 14 d
Adherence
Companion88.8 %
stable · +0.6 vs previous 14 d
Sleep quality
Wearable40.9/100
stable · +0.2 vs previous 14 d
Glucose, CGM daily mean
CGM121 mg/dL
stable · +0.9 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 98 from the failing basin, 15 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +6.6
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -3.5 next day
Main detractors to watch
- Enterobacteriaceae elevatedhidden · steering -7.4
- Antibiotic courseperturbation · steering -4.7
- Poor-sleep weekperturbation · steering -3
- Alcohol on dosing daysperturbation · steering -1.8
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.5supporter · 95%
- Histamine load+1.4no signal · 46%
- Alcohol+1.3no signal · 42%
- Insoluble fibre+0.9no signal · 29%
- Ultra-processed food-0.6no signal · 15%
- Simple carbohydrates+0.4no signal · 15%
- Caffeine-0.4no signal · 15%
- Dietary fat load-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑25
- WearableResting HR 72 bpm
- Inflammatory signalling ↓15
- WearableHRV 37 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 4.2 · butyrate capacity 68/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 6.8 h
- Steps
- 3,775
- Resting HR
- 73 bpm
Daily log: GI score 5, nutritional resilience 73, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02249 | 32% | S09 | DT-01 | improved | 100 |
| P-02189 | 32% | S17 | — | — | 96 |
| P-02242 | 32% | S20 | — | — | 95 |
| P-02013 | 33% | S14 | BR-03 | no change | 94 |
| P-02104 | 34% | S15 | — | — | 94 |
| P-02450 | 35% | S12 | NP-02 | improved | 92 |
| P-02277 | 35% | S05 | AD-05 | improved | 92 |
| P-02304 | 33% | S15 | — | — | 92 |
| P-02653 | 33% | S14 | — | — | 91 |
| P-02689 | 32% | S13 | — | — | 91 |
| P-02069 | 38% | S19 | — | — | 91 |
| P-02481 | 32% | S05 | — | — | 91 |